MYDA Advisors’s GeneDx Holdings WGS Stock Holding History

MYDA Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,636	Closed	-$368K	–	250
2022 Q1	$368K	Buy	3,636 +606	+20%	+$67.4K	0.15%	126
2021 Q4	$446K	Buy	+3,030	New	+$677K	0.12%	162
2021 Q3	–	Sell	-3,939	Closed	-$1.82M	–	309
2021 Q2	$1.82M	Buy	3,939 +909	+30%	+$390K	0.45%	70
2021 Q1	$1.49M	Buy	+3,030	New	+$1.58M	0.41%	77

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

MYDA Advisors's WGS Position: Q2 2022 in Review

MYDA Advisors sold out of GeneDx Holdings (WGS) in Q2 2022, closing a stake of 3,636 shares — an estimated $368K sold.

MYDA Advisors first reported a position in WGS in Q1 2021 and held it in 4 quarters. The position peaked at $1.82M in Q2 2021. 111 funds tracked by Wall St. Rank hold WGS as of Q2 2022.

MYDA Advisors reported no remaining GeneDx Holdings position as of Q2 2022 after selling out during the quarter.
MYDA Advisors sold 3,636 GeneDx Holdings shares in Q2 2022, an estimated $368K.
MYDA Advisors first reported a position in GeneDx Holdings in Q1 2021 and held it in 4 quarters.
MYDA Advisors's GeneDx Holdings position peaked at $1.82M in Q2 2021.
111 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2022.

Based on MYDA Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.